Morocco’s ministerial committee upholding the environmental approval for Emmerson plc’s potash project and referring it back to the original body, CRUI, is another step forward believes Liberum.
“In our view, this is a positive development, if second prize to outright approval, in that it allows Khemisset to move forward,” said the broker.
Powerhouse Energy and Hydrogen Utopia have agreed on terms for the joint development of a non-recyclable plastic waste-to-hydrogen facility site at Longford, Republic of Ireland.
Work had been paused on the project in October while the two companies assessed their options, but an agreement to move forward has now been reached.
Chariot Ltd (AIM:CHAR, OTC:OIGLF) has completed a feasibility study for its proposed large-scale green hydrogen project in Mauritania.
Dubbed Project Nour, the joint-venture between subsidiary Chariot Green Hydrogen and part TotalEnergies-owned TE H2 would be among the world’s largest, with 10 gigawatts of capacity.
Zephyr Energy PLC (AIM:ZPHR, OTCQB:ZPHRF) is now counting down to the next important phase of operations at the Paradox project, in Utah, where drilling is expected to begin in mid-April.
The company, in a statement, said it is in the final stages of planning for the redrill of the State 36-2 well with insurance expected to cover a significant portion of the redrill costs.
Tirupati Graphite PLC (LSE:TGR, OTCQX:TGRHF) said it has completed the latest exploration and resource drilling programme at its two Madagascan flake graphite projects.
An updated Competent Persons Report (CPR) is now being prepared by SRK Consulting and is expected to be published in the near term.
88 Energy Ltd (AIM:88E, ASX:88E, OTC:EEENF) has announced the start of flow test operations at the Hickory-1 well, part of Project Phoenix in Alaska.
The programme is evaluating the USFS zones, starting with the Upper SFS followed by the SMD-B reservoir.
Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) has announced significant advancements in its Midkine mRNA and STAT-6 siRNA oncology programmes, marking important milestones in pre-clinical development aimed at combating liver and colorectal cancers.
In the company's latest update on its Midkine mRNA asset, experiments conducted in validated in vivo models of liver cancer demonstrated the safety and efficacy of a new mRNA therapy combined with a lipid nanoparticle (LNP) delivery system.
Emmerson plc said Morocco's Commission Ministérielle de Pilotage (Ministerial Committee) has referred environmental approval of the Khemisset Potash project back to the Commission Régionale Unifiée d'Investissement (CRUI).
AIM-listed Emmerson referred the original decision of the CRUI regarding the project's environmental approval in July 2023 to the Ministerial Committee.